The global neurovascular devices market size reached US$ 2.7 Billion in 2022. Looking forward, the analyst expects the market to reach US$ 3.9 Billion by 2028, exhibiting a growth rate (CAGR) of 5.9% during 2023-2028.
Neurovascular devices, also known as interventional neurology devices, are used to treat neurovascular disorders, such as ischemic stroke aneurysms, stenosis, arteriovenous malformation, and fistulas. They include embolic coils, liquid embolic agents, flow diversion devices, arterial stents, catheters, and guidewires. They allow physicians to gain endovascular access to the treatment areas in the brain and provide efficient treatment. As a result, they are gaining immense traction in the healthcare industry and are extensively used in the treatment and diagnosis of numerous peripheral and central nervous system disorders and ailments.
2. What is the expected growth rate of the global neurovascular devices market during 2023-2028?
3. What are the key factors driving the global neurovascular devices market?
4. What has been the impact of COVID-19 on the global neurovascular devices market?
5. What is the breakup of the global neurovascular devices market based on the product?
6. What is the breakup of the global neurovascular devices market based on end user?
7. What are the key regions in the global neurovascular devices market?
8. Who are the key players/companies in the global neurovascular devices market?
Neurovascular devices, also known as interventional neurology devices, are used to treat neurovascular disorders, such as ischemic stroke aneurysms, stenosis, arteriovenous malformation, and fistulas. They include embolic coils, liquid embolic agents, flow diversion devices, arterial stents, catheters, and guidewires. They allow physicians to gain endovascular access to the treatment areas in the brain and provide efficient treatment. As a result, they are gaining immense traction in the healthcare industry and are extensively used in the treatment and diagnosis of numerous peripheral and central nervous system disorders and ailments.
Neurovascular Devices Market Trends:
The growing global geriatric population, which is highly susceptible to acquiring these disorders, represents one of the key factors positively influencing the market. These disorders cause moderate to severe damage to the brain, resulting in conditions like strokes and cerebral hemorrhage. This, along with the rising lifestyle disorders, such as obesity, is catalyzing the demand for neurovascular devices across the globe. In addition, rapid urbanization, sedentary lifestyles, and stress are resulting in rising incidences of stroke, which, in turn, is increasing the need for neurovascular devices. The rising awareness among patients about the easy availability of treatment and reimbursement for neurological disorders is increasing the adoption of these devices and strengthening the growth of the market. Furthermore, technological advancements in neurovascular treatments and government initiatives to modernize healthcare infrastructure across the globe are offering a favorable market outlook. Additionally, various initiatives are being undertaken by governments of various countries to generate awareness among the general population about symptoms and measures to be taken in case of emergency and available treatment options. Moreover, rapid expansion of hospitals and surgical centers, ambulatory care centers, research laboratories, and academic institutes is increasing the requirement for neurovascular devices worldwide.Key Market Segmentation
The report provides an analysis of the key trends in each sub-segment of the global neurovascular devices market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, application and end user.Breakup by Product:
- Cerebral Embolization and Aneurysm Coiling Devices
- Embolic Coils
- Flow Diverters
- Liquid Embolic Agents
- Cerebral Angioplasty and Stenting Systems
- Carotid Artery Stents
- Embolic Protection Devices
- Neurothrombectomy Devices
- Clot Retrieval Devices
- Suction Devices
- Vascular Snares
- Support Devices
- Micro Catheters
- Micro Guidewires
Breakup by Application:
- Ischemic Stroke
- Aneurysm
- Arteriovenous Malformation and Fistulas (AVM)
- Stenosis
- Others
Breakup by End User:
- Hospitals
- Ambulatory Surgical Centers
- Clinics
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape
The competitive landscape of the industry has also been examined along with the profiles of the key players being Acandis GmbH, Asahi Intecc Co. Ltd., Imperative Care Inc., Integer Holdings Corporation, Johnson & Johnson, Medtronic plc, MicroPort Scientific Corporation, Penumbra Inc., Perflow Medical Ltd., Rapid Medical, Stryker Corporation and Terumo Corporation.Key Questions Answered in This Report
1. What was the size of the global neurovascular devices market in 2022?2. What is the expected growth rate of the global neurovascular devices market during 2023-2028?
3. What are the key factors driving the global neurovascular devices market?
4. What has been the impact of COVID-19 on the global neurovascular devices market?
5. What is the breakup of the global neurovascular devices market based on the product?
6. What is the breakup of the global neurovascular devices market based on end user?
7. What are the key regions in the global neurovascular devices market?
8. Who are the key players/companies in the global neurovascular devices market?
Table of Contents
1 Preface3 Executive Summary11 Value Chain Analysis13 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Neurovascular Devices Market
6 Market Breakup by Product
7 Market Breakup by Application
8 Market Breakup by End User
9 Market Breakup by Region
10 SWOT Analysis
12 Porters Five Forces Analysis
14 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Acandis GmbH
- Asahi Intecc Co. Ltd.
- Imperative Care Inc.
- Integer Holdings Corporation
- Johnson & Johnson
- Medtronic plc
- MicroPort Scientific Corporation
- Penumbra Inc.
- Perflow Medical Ltd.
- Rapid Medical
- Stryker Corporation
- Terumo Corporation
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 143 |
| Published | October 2023 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 2.74 Billion |
| Forecasted Market Value ( USD | $ 3.9 Billion |
| Compound Annual Growth Rate | 6.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
